Inoperable stage III EGFR mutant non-small-cell lung cancer: time for drug first, local later?

Ann Oncol. 2024 Dec;35(12):1074-1076. doi: 10.1016/j.annonc.2024.10.005. Epub 2024 Oct 11.
No abstract available

Publication types

  • Editorial